首页>
外国专利>
Pyridopyrimidinone inhibitor of pi3k alpha for use in combination with one or more chemotherapeutic agents selected from taxol, rapamycin, carboplatin and erlotinib for the treatment of cancer
Pyridopyrimidinone inhibitor of pi3k alpha for use in combination with one or more chemotherapeutic agents selected from taxol, rapamycin, carboplatin and erlotinib for the treatment of cancer
The present invention provides methods of treating cancer by administering a compound of Formula I, optionally as a pharmaceutically acceptable salt, solvate and/or hydrate thereof, in combination with other cancer treatments. (Formula I)
展开▼